Offer - Urjas Oil for just ₹ 1 X
Alphadopa 250 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. High BP are some of its major therapeutic uses. Alphadopa 250 Mg Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Alphadopa 250 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Common side effects of Alphadopa 250 Mg Tablet include Headache, Dry Mouth, Drowsiness. Some other side effects of Alphadopa 250 Mg Tablet have been listed ahead. These side effects of Alphadopa 250 Mg Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Alphadopa 250 Mg Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. Further, the section on Alphadopa 250 Mg Tablet related warnings talks about Alphadopa 250 Mg Tablet's effects on the liver, heart and kidney.
The section on Alphadopa 250 Mg Tablet contraindications lists all such conditions.
Drug interactions for Alphadopa 250 Mg Tablet have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Alphadopa 250 Mg Tablet is considered not safe while driving, and is not addictive.
Alphadopa 250 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Alphadopa 250 Mg Tablet safe for pregnant women?
Alphadopa can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Alphadopa 250 Mg Tablet safe during breastfeeding?
Side effects of Alphadopa for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Alphadopa 250 Mg Tablet on the Kidneys?
Alphadopa rarely harms the kidneys.
What is the effect of Alphadopa 250 Mg Tablet on the Liver?
Very few cases of side effects of Alphadopa on the liver have been reported.
What is the effect of Alphadopa 250 Mg Tablet on the Heart?
Side effects of Alphadopa rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Alphadopa 250 Mg Tablet unless your doctor advises you to do so -
Is this Alphadopa 250 Mg Tablet habit forming or addictive?
No, there is no any evidence that Alphadopa 250 Mg Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Alphadopa 250 Mg Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Alphadopa 250 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Alphadopa 250 Mg Tablet in mental disorders is not effective.
Interaction between Food and Alphadopa 250 Mg Tablet
Taking Alphadopa 250 Mg Tablet with food is safe.
Interaction between Alcohol and Alphadopa 250 Mg Tablet
Consult your doctor before consuming alcohol while taking Alphadopa 250 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aldomet® (methyldopa)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 566
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 835-837